ANUM GAFFAR: Open Payments
NPI 1326657560 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 18 payments from 9 companies in 2025. Trend: 2023 $239 · 2024 $574 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $296 |
| Boston Scientific Corporation | 2 | $184 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| ABBVIE INC. | 2 | $46 |
| Smith+Nephew, Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Endo USA, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| Laborie Medical Technologies Corp. | 1 | $13 |
Products named: INTERSTIM, Axonics, ORGOVYX, STRAVIX, ADSTILADRIN, VENCLEXTA, AVEED, GEMTESA.
Industry payments across GA — which companies pay providers there.
